Hypertrophic cardiomyopathy (HCM) is a familial cardiac disease manifested in a wide phenotype and diverse genotype and, thus, presenting unpredictable risks mainly on young adults. Extensive studies are being conducted to categorize patients and link phenotype with genotype for a better management and control of the disease with all its complications. Because the full mechanisms behind HCM are still not revealed, therapeutics are not definitive. Further research is to be conducted for the generation of a complete picture and directed therapy for HCM.
Keywords: Genotype; Hypertrophic cardiomyopathy; Left ventricle; Muscle-bound heart; Phenotype.
Copyright © 2016 Elsevier Inc. All rights reserved.